Predicting Relapse in CML: A New Approach
Chronic myeloid leukemia (CML) patients face a tough question after hitting remission: what's next? Doctors often lack clear guidelines for managing care at this stage. A recent study tackles this issue by creating a model to predict the risk of relapse. The model focuses on early changes in BCR::AB